Status:
RECRUITING
Bioimpedence and Arterial Function Monitoring at Birth and in Infants
Lead Sponsor:
Imperial College Healthcare NHS Trust
Conditions:
Arterial Stiffness
Fetal Growth Retardation
Eligibility:
All Genders
Up to 6 years
Brief Summary
Babies may be born appropriately grown for gestational age (AGA, \>10th centile) or small for gestational age (SGA, \<10th centile). Babies who are SGA and have evidence in utero of vascular compromis...
Eligibility Criteria
Inclusion
- Healthy term infants (including those with SGA+/-FGR) in the postnatal ward
- Term and Preterm infants (including those with SGA+/-FGR) admitted to the neonatal unit
- Written informed parental consent
Exclusion
- Antenatal or postnatal diagnosis of complex/life-limiting congenital anomaly or genetic condition
- Infants with no realistic chance of survival
- Infants with fragile skin not permitting use of cuffs for research purposes
- Babies whose parents have a limited understanding of English will be excluded in the event that communication via NHS translation services is not possible due to clinical demands on these services
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04720690
Start Date
December 1 2020
End Date
December 31 2024
Last Update
July 29 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Charlotte's and Chelsea Hospital
London, United Kingdom, W120HS
2
St Mary's Hospital
London, United Kingdom, W21NY